Henry Meds Review

Henry Meds: a mainstream pick for people who want options

Henry Meds is one of the more established names in compounded GLP-1 telehealth, and its main appeal is breadth. Most online weight-loss programs hand you a single drug in a single format and call it a day. Henry Meds gives you both semaglutide and tirzepatide, and unusually, it offers them as either a weekly injection or an oral version. If you are needle-averse, or you simply want the freedom to switch medications or formats without changing providers, that flexibility is the real reason to look here.

This is a solid, middle-of-the-road choice rather than a budget standout. Its everyday pricing sits above the category median, and the trade-off you are paying for is selection and an all-inclusive plan, not the lowest possible number.

How the pricing actually works

Henry Meds uses a plan price that scales with the medication and dose you are on, so there is no single sticker number that applies to everyone. The company describes its plans as starting at a low intro figure and rising as your dose climbs, with a typical ongoing cost landing around $249 a month for many patients. For context, the category median across the providers we track is about $169, so Henry sits on the pricier side of the field.

What you do get for that price is genuinely bundled. Henry is explicit that your provider visits, the medication itself, supplies, shipping, and ongoing care are all rolled into the plan price, with no separate consult fee and what it describes as no hidden or surprise charges. That matters, because some cheaper-looking competitors bolt on a membership or visit fee that erases the difference. Henry does not run a one-time teaser rate to lure you in; the entry price is just the bottom of the dose ladder.

• Injectable semaglutide — the standard weekly shot most patients picture
• Oral semaglutide — a daily option for people who would rather skip needles entirely
• Tirzepatide — the dual-action medication, priced higher and scaling further as the dose increases
• Everything bundled — visits, medication, supplies, shipping, and follow-up care in one plan price

The medications and how you get them

Everything Henry dispenses for weight management is compounded, not brand-name. That is the standard model for affordable GLP-1 access right now, and it is the reason the monthly cost is a fraction of the over-a-thousand-dollars-a-month list price you would face for branded pens at the pharmacy counter. It also means you are relying on a compounding pharmacy rather than the original manufacturer, which is a genuine distinction worth understanding before you sign up.

The format choice is where Henry earns its keep. Offering compounded semaglutide as both an injection and an oral, plus tirzepatide on top, covers most of the decisions a new patient might agonize over. You can start oral to see how you tolerate the medication and move to the injection later, or step up from semaglutide to tirzepatide if your results stall, all without leaving the platform.

What sets Henry apart — and where it stays quiet

Henry's differentiator is simple: it is a known, high-volume operator with the widest everyday menu among compounded providers. For a lot of people, that name recognition and one-stop selection is exactly what they want from a first GLP-1 program.

The honest flip side is that Henry is less transparent than we would like on the operational details. It does not publish the list of states it serves; the site only tells you to check whether you live or have an address in a supported state, and one notable wrinkle is that California orders can take longer to fulfill because of additional compound testing. It also names no specific accredited compounding pharmacy partner in its public materials, and overall there is limited public information about the finer points of the program. None of that is a red flag on its own, but it does mean you will confirm some specifics only after you start the intake.

Who should choose it — and who should skip it

Choose Henry Meds if you value flexibility and a trusted name over rock-bottom pricing: you want both major GLP-1 drugs available, you might want the oral option, and you would rather have one bundled, no-surprise-fee plan than hunt for the cheapest line item. It is a particularly comfortable on-ramp for first-timers who want mainstream, well-trodden access.

Skip it if price is your single deciding factor — several compounded providers undercut Henry's ongoing rate. Also think twice if you live in California and need medication fast, or if you are the kind of shopper who wants every detail (exact state coverage, the named pharmacy) spelled out before you hand over any information, since Henry holds some of that back until intake.

Trust, safety, and medical oversight

There are no FDA warning letters on file for Henry Meds in our records, which is a positive baseline. Treatment is delivered through licensed providers, and the GLP-1 weight-management offering was live-verified by our editors. At the same time, our confidence is tempered by the disclosure gaps noted above: because Henry does not publicly name its compounding pharmacy or its accreditation, we cannot independently vouch for that part of the supply chain the way we can with providers who publish it. You can see how we weigh these factors in our scoring methodology.

The bottom line

Henry Meds is a dependable, flexible, mainstream choice that trades the lowest price for the widest selection and a clean, all-inclusive plan. The medication menu — semaglutide and tirzepatide, oral and injectable — is its strongest card, and the no-extra-fees structure is reassuring. Just go in knowing you will pay a bit above the category median, that California fulfillment runs slow, and that a few program specifics only surface once you start the intake. For many people that is a fair deal; bargain hunters and detail-demanders can do better elsewhere.

If you're weighing alternatives, Wellorithm ($247/month) and Direct Meds ($249/month) are among the closest options we track to Henry Meds.